Pharmacogenomic Advances in the Prediction and Prevention of Cutaneous Idiosyncratic Drug Reactions

2017 ◽  
Vol 102 (1) ◽  
pp. 86-97 ◽  
Author(s):  
R-Y Pan ◽  
R-L Dao ◽  
S-I Hung ◽  
W-H Chung
1995 ◽  
Vol 61 ◽  
pp. 163-170 ◽  
Author(s):  
Jack P. Uetrecht

Reactive metabolites are believed to be responsible for many types of toxicity, including idiosyncratic drug reactions. Bone marrow is a frequent target of idiosyncratic reactions, and, since these reactions have characteristics that suggest involvement of the immune system, the formation of reactive metabolites by leucocytes could also play a role in the aetiology of idiosyncratic drug reactions. The major oxidation system in neutrophils and monocytes is a combination of NADPH oxidase and myeloperoxidase. This system oxidizes primary arylamines, such as sulphonamides, to reactive metabolites and these drugs are also associated with a high incidence of agranulocytosis, generalized idiosyncratic reactions and/ or drug-induced lupus. Clozapine is oxidized by this system to a relatively stable nitrenium ion; clozapine is also associated with a high incidence of agranulocytosis. Arylamines that have an oxygen or nitrogen in the para position, such as amodiaquine, vesnarinone and 5-aminosalicylic acid, are oxidized to quinone-like reactive intermediates. Aminopyrine is oxidized to a very reactive dication. Such reactive metabolites could also inhibit neutrophil function and mediate some of the therapeutic effects of these drugs: for example, the use of dapsone for dermatitis herpetiformis and the use of 5-aminosalicylic acid for inflammatory bowel disease.


2002 ◽  
Vol 142 (1-2) ◽  
pp. 99-117 ◽  
Author(s):  
Christine M Dieckhaus ◽  
Charles D Thompson ◽  
Shane G Roller ◽  
Timothy L Macdonald

2011 ◽  
Vol 44 (3) ◽  
pp. 467 ◽  
Author(s):  
IO Fadeyibi ◽  
FO Ajose ◽  
OI Akinola ◽  
SA Ademiluyi ◽  
PI Jewo

Sign in / Sign up

Export Citation Format

Share Document